Research Library

All Sources,
In One Place

Every citation from every published lesson, grouped by topic. Click through to read the primary literature directly.

BDNF & Neuroplasticity

25 sources Read Lesson →

Purification of a new neurotrophic factor from mammalian brain

Barde YA, Edgar D, Thoenen H — EMBO J. 1982

Neurotrophin-regulated signalling pathways

Reichardt LF — Philos Trans R Soc Lond B Biol Sci. 2006

PubMed ↗

A synaptic model of memory: long-term potentiation in the hippocampus

Bliss TV, Collingridge GL — Nature. 1993

PubMed ↗

Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain

Hofer M, et al. — EMBO J. 1990

BDNF and adult neurogenesis in the hippocampus

Bhanu SS, et al. — Neuroscience. 2019

PubMed ↗

BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

Lu B, et al. — Nat Rev Neurosci. 2013

PubMed ↗

A neurotrophic model for stress-related mood disorders

Duman RS, Monteggia LM — Biol Psychiatry. 2006

PubMed ↗

Potential therapeutic uses of BDNF in neurological and psychiatric disorders

Nagahara AH, Tuszynski MH — Nat Rev Drug Discov. 2011

PubMed ↗

Neonatal isolation, behavioural and neurochemical changes in adult rats

Bhagya V, et al. — Eur J Pharmacol. 2017

Voluntary exercise protects against stress-induced decreases in BDNF protein expression

Adlard PA, Cotman CW — Neuroscience. 2004

PubMed ↗

Sleep deprivation effects on growth factor expression in neonatal rats: a potential role for BDNF

Hairston IS, et al. — J Sleep Res. 2004

PubMed ↗

A high-fat, refined sugar diet reduces hippocampal BDNF, neuronal plasticity, and learning

Molteni R, et al. — Neuroscience. 2002

PubMed ↗

Alcohol and BDNF

Bhave SV, et al. — Drug Alcohol Depend. 1999

A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor

Szuhany KL, et al. — J Psychiatr Res. 2015

PubMed ↗

Intermittent metabolic switching, neuroplasticity and brain health

Mattson MP, et al. — Nat Rev Neurosci. 2018

PubMed ↗

Neurobiology of the stress response: contribution of the sympathetic nervous system

Molina PE — Front Integr Neurosci. 2010

Short-term head-out whole-body cold-water immersion facilitates positive affect and increases interaction between large-scale brain networks

Yankouskaya A, et al. — Biology. 2023

n-3 fatty acids: role in neurogenesis and neuroplasticity

Crupi R, et al. — Curr Med Chem. 2013

PubMed ↗

Neuroinflammation, neurodegeneration, and depression

Hurley LL, Tizabi Y — Neurotox Res. 2013

PubMed ↗

Improving effects of the mushroom Yamabushitake on mild cognitive impairment

Mori K, et al. — Phytother Res. 2009

PubMed ↗

The role of BDNF and its receptors in depression and antidepressant drug action

Castrén E, Rantamäki T — Pharmacol Ther. 2010

PubMed ↗

BDNF release is required for the behavioral actions of ketamine

Lepack AE, et al. — Int J Neuropsychopharmacol. 2014

PubMed ↗

Targeting Wnt signaling in the treatment of bipolar disorder

Quiroz JA, et al. — Expert Opin Ther Targets. 2010

Semax, an analogue of ACTH(4-7), regulates BDNF and trkB expression in the rat hippocampus

Dolotov OV, et al. — J Neurochem. 2006

PubMed ↗

Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery

Sikiric P, et al. — J Orthop Surg Res. 2018

SSRIs & SNRIs

14 sources Read Lesson →

Biogenic amine transporters: regulation in flux

Blakely RD, Bauman AL — Curr Opin Neurobiol. 2000

PubMed ↗

Stahl's Essential Psychopharmacology. 4th ed.

Stahl SM — Cambridge University Press. 2013

Current advances and trends in the treatment of depression

Blier P, de Montigny C — Trends Pharmacol Sci. 1994

PubMed ↗

Serotonin and depression: a disconnect between the advertisements and the scientific literature

Lacasse JR, Leo J — PLoS Med. 2005

PubMed ↗

The serotonin theory of depression: a systematic umbrella review of the evidence

Moncrieff J, et al. — Mol Psychiatry. 2022

PubMed ↗

Is mood chemistry?

Castrén E — Nat Rev Neurosci. 2005

PubMed ↗

The importance of norepinephrine in depression

Moret C, Briley M — Neuropsychiatr Dis Treat. 2011

PubMed ↗

Effects of antidepressants on cognitive function in patients with MDD

Keefe RS, et al. — CNS Spectr. 2014

PubMed ↗

Cognitive deficits and functional outcomes in major depressive disorder

McIntyre RS, et al. — Can J Psychiatry. 2013

PubMed ↗

Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study

Price J, et al. — Br J Psychiatry. 2009

PubMed ↗

The role of BDNF and its receptors in depression and antidepressant drug action

Castrén E, Rantamäki T — Pharmacol Ther. 2010

PubMed ↗

A neurotrophic model for stress-related mood disorders

Duman RS, Monteggia LM — Biol Psychiatry. 2006

PubMed ↗

Antidepressant drug treatment and hippocampal neurogenesis

Sheline YI, et al. — Dialogues Clin Neurosci. 2011

PubMed ↗

Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review

Fava GA, et al. — Psychother Psychosom. 2015

PubMed ↗

Amphetamines & Stimulants

15 sources Read Lesson →

Mechanisms of neurotransmitter release by amphetamines: a review

Sulzer D, et al. — Prog Neurobiol. 2005

PubMed ↗

New insights into the mechanism of action of amphetamines

Fleckenstein AE, et al. — Annu Rev Pharmacol Toxicol. 2007

PubMed ↗

Monoamine transporters and psychostimulant drugs

Rothman RB, Baumann MH — Eur J Pharmacol. 2003

PubMed ↗

Amphetamine, past and present — a pharmacological and clinical perspective

Heal DJ, et al. — J Psychopharmacol. 2013

PubMed ↗

Ice: a new dosage form of an old drug

Cho AK — Science. 1990

PubMed ↗

Abuse of amphetamines and structural abnormalities in the brain

Berman SM, et al. — Ann NY Acad Sci. 2008

PubMed ↗

Mechanism of action of stimulants in attention-deficit/hyperactivity disorder

Stahl SM — J Clin Psychiatry. 2010

PubMed ↗

Dopamine and glutamate in ADHD: implications for new research strategies

Swanson JM, et al. — Neurosci Biobehav Rev. 2017

Pharmacokinetics of dexmethylphenidate

Quinn D, et al. — J Child Adolesc Psychopharmacol. 2004

The pharmacology of amphetamine and methylphenidate: relevance to the neurobiology of ADHD

Faraone SV — Neurosci Biobehav Rev. 2018

PubMed ↗

Prescription stimulants' effects on healthy inhibitory control, working memory, and episodic memory: a meta-analysis

Ilieva IP, et al. — J Cogn Neurosci. 2015

PubMed ↗

Catecholamine influences on dorsolateral prefrontal cortical networks

Arnsten AF — Biol Psychiatry. 2011

PubMed ↗

Brain dopamine transporter alterations in stimulant use disorder

Leroy C, et al. — Eur J Nucl Med Mol Imaging. 2012

European consensus statement on diagnosis and treatment of adult ADHD

Kooij SJ, et al. — BMC Psychiatry. 2010

PubMed ↗

Assessing long-term effects of MDMA on serotonergic axon terminals

Ricaurte GA, McCann UD — NIDA Res Monogr. 1996

Wakefulness Agents

19 sources Read Lesson →

Neurons containing hypocretin (orexin) project to multiple neuronal systems

Peyron C, et al. — J Neurosci. 1998

PubMed ↗

Reduced number of hypocretin neurons in human narcolepsy

Thannickal TC, et al. — Neuron. 2000

PubMed ↗

The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness

Sakurai T — Nat Rev Neurosci. 2007

PubMed ↗

The unique profile of modafinil: investigation of neurochemical and behavioral effects in comparison with methylphenidate and amphetamine

Mereu M, et al. — Behav Pharmacol. 2013

PubMed ↗

Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil

Zolkowska D, et al. — J Pharmacol Exp Ther. 2009

PubMed ↗

Modafinil increases histamine release in the anterior hypothalamus of rats

Ishizuka T, et al. — Neurosci Lett. 2003

PubMed ↗

Effects of modafinil on dopamine and dopamine transporters in the male human brain

Volkow ND, et al. — JAMA. 2009

PubMed ↗

Clinical pharmacokinetic profile of modafinil

Robertson P Jr, Hellriegel ET — Clin Pharmacokinet. 2003

PubMed ↗

Effects of modafinil on sustained attention performance and quality of life in OSA patients

Dinges DF, Weaver TE — Sleep Med. 2003

Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives

Darwish M, et al. — Clin Drug Investig. 2009

PubMed ↗

Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review

Battleday RM, Brem AK — Eur Neuropsychopharmacol. 2015

PubMed ↗

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use

Fredholm BB, et al. — Pharmacol Rev. 1999

PubMed ↗

Adenosine, energy metabolism and sleep homeostasis

Porkka-Heiskanen T, Kalinchuk AV — Sleep Med Rev. 2011

PubMed ↗

Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans

Dijk DJ, Czeisler CA — J Neurosci. 1995

PubMed ↗

Is caffeine a cognitive enhancer?

Nehlig A — J Alzheimers Dis. 2010

PubMed ↗

An update on the mechanisms of the psychostimulant effects of caffeine

Ferré S — J Neurochem. 2008

PubMed ↗

Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels

Lovallo WR, et al. — Psychosom Med. 2005

PubMed ↗

Genetics of caffeine consumption and responses to caffeine

Yang A, et al. — Psychopharmacology. 2010

PubMed ↗

Caffeine withdrawal: a parametric analysis of caffeine dosing conditions

Evans SM, Griffiths RR — J Pharmacol Exp Ther. 1999

PubMed ↗
@100xyanni